There are growing discussions regarding the term “cancer survivor,” particularly how patients with cancer relate to it.
To assess how individuals diagnosed with colorectal cancer (CRC) perceive the term “cancer survivor.”
We conducted an international cross-sectional study and, using social media, invited individuals who were ≥18 years; received a diagnosis for CRC; and can communicate in English. We administered an online survey comprising both quantitative (e.g., multiple choice) and qualitative (e.g., open-ended) questions. We used logistic regression to assess determinants of participants’ perspectives towards the term “cancer survivor.” Qualitative responses were analyzed using content analysis.
In all, 539 participants with CRC completed the survey, including 122 (22.6%) undergoing treatment and 417 (77.4%) who completed treatment. Participants who had completed treatment were four times more likely to relate with term “cancer survivor” compared to those undergoing treatment (adjusted odds ratio (aOR), 4.0; 95% confidence interval (CI) 2.4 to 6.7). Participants diagnosed with CRC ≥50 years were also more likely to relate with the term compared to those diagnosed < 50 years (aOR, 1.88; 95% (CI) 1.2 to 3.0). Analysis of open-ended survey responses revealed aversion, discomfort, indifference, reluctance, and acceptance as themes which capture the spectrum of feelings towards the term “cancer survivor.”
Perspectives of individuals with CRC towards the term “cancer survivor” differ according to treatment status and age of diagnosis.
Implication of Cancer Survivors
Our study amplifies voices of the CRC community towards reconsideration of the term “cancer survivor”, considering the implications of treatment status and age in highlighting the importance of language.
This is a preview of subscription content, access via your institution.
Buy single article
Instant access to the full article PDF.
Price excludes VAT (USA)
Tax calculation will be finalised during checkout.
Surbone A, Annunziata MA, Santoro A, Tirelli U, Tralongo P. Cancer patients and survivors: changing words or changing culture? Ann Oncol. 2013;24(10):2468–71.
Rowland JH, Hewitt M, Ganz PA. Cancer survivorship: a new challenge in delivering quality cancer care. J Clin Oncol. 2006;24(32):5101–4.
Cheung SY, Delfabbro P. Are you a cancer survivor? A review on cancer identity. J Cancer Surviv. 2016;10(4):759–71.
Twombly R. What’s in a name - who is a cancer survivor. J Natl Cancer Inst. 2004;96(19):1414–5.
Wolinsky H. I have cancer. Please don’t call me a ‘survivor’ 2019. Available from: https://www.medpagetoday.com/special-reports/apatientsjourney/79229. Accessed 4 Sept 2020.
Berry LL, Davis SW, Godfrey Flynn A, Landercasper J, Deming KA. Is it time to reconsider the term “cancer survivor”? J Psychosoc Oncol. 2019;37(4):413–26.
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424.
Chambers SK, Baade P, Meng X, Youl P, Aitken J, Dunn J. Survivor identity after colorectal cancer: antecedents, prevalence and outcomes. Psychooncology. 2012;21(9):962–9.
Charmaz K. The body, identity, and self: adapting to impairment. Sociol Q. 1995;36:657–60.
Araujo L, Breau G, George M, Gastonguay L, Brown E, De Vera M. Shared experiences of diagnosis and treatment of young-onset colorectal cancer: a patient-oriented qualitative study. J Psychosoc Oncol Res Pract. 2020;2(1):e17.
Dau H, El Din KS, McTaggart-Cowan H, Loree JM, Gill S, De Vera MA. Health information seeking behaviors among individuals with young-onset and average-onset colorectal cancer: an international cross-sectional survey. Support Care Cancer. 2020;28:6011–21.
EQ-5D The Netherlands: EuroQol Research Foundation; Available from: https://euroqol.org/eq-5d-instruments/how-can-eq-5d-be-used/. Accessed 24 Feb 2020.
Kim SH, Hwang JS, Kim TW, Hong YS, Jo M-W. Validity and reliability of the EQ-5D for cancer patients in Korea. Support Care Cancer. 2012;20(12):3155–60.
Xie F, Pullenayegum E, Gaebel K, Bansback N, Bryan S, Ohinmaa A, et al. A time tradeoff derived value set of the EQ-5d-5L for Canada. Med Care. 2016;54:98–105.
Elo S, Kyngäs H. The qualitative content analysis process. J Adv Nurs. 2008;62(1):107–15.
Abdelsattar ZM, Wong SL, Regenbogen SE, Jomaa DM, Hardiman KM, Hendren S. Colorectal cancer outcomes and treatment patterns in patients too young for average-risk screening. Cancer. 2016;122(6):929–34.
Siegel RL, Torre LA, Soerjomataram I, Hayes RB, Bray F, Weber TK, et al. Global patterns and trends in colorectal cancer incidence in young adults. Gut. 2019;68(12):2179–85.
Saad El Din K, Loree JM, Sayre EC, Gill S, Brown CJ, Dau H, et al. Trends in the epidemiology of young-onset colorectal cancer: a worldwide systematic review. BMC Cancer. 2020;20(1):288.
Bellizzi KM, Blank TO. Cancer-related identity and positive affect in survivors of prostate cancer. J Cancer Surviv. 2007;1(1):44–8.
King DB, O’Rourke N, DeLongis A. Social media recruitment and online data collection: a beginner’s guide and best practices for accessing low-prevalence and hard-to-reach populations. Can Psychol. 2014;55(4):240–9.
We thank all of the participants for taking the time to share their experiences and perspectives for our study. We thank the following organizations for their support with promoting the study survey through their networks: Colorectal Cancer Canada and COLONTOWN®
Dr. De Vera holds a Tier 2 Canada Research Chair and is a recipient of a Scholar Award from the Michael Smith Foundation for Health Research.
Yes, we are in compliance with the ethical statement. We received ethical approval.
All participants declared informed consent.
Conflict of interest
The authors declare no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Wee, M., Dau, H., Gastonguay, L. et al. How do individuals with colorectal cancer perceive the term “cancer survivor”: a cross-sectional survey. J Cancer Surviv 16, 257–268 (2022). https://doi.org/10.1007/s11764-021-01015-9